NCT00001567View on ClinicalTrials.gov

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

January 31, 1997

Study Completion Date

April 30, 2002

Conditions
Hairy Cell Leukemia
Interventions
DRUG

Roferon-A

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00001567 - A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia | Biotech Hunter | Biotech Hunter